top of page

Knocking down of Xkr8 enhances chemotherapy efficacy through modulating tumor immune microenvironment

Conner McCarthy
Aug 16, 2024
0 min read

Recent Posts

Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy

The multifaceted chemo-immune resistance is the principal barrier to achieving cure in cancer patients. Identifying a target that is...

Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

SirnaMed Featured in this example news article

Comments

bottom of page